MAPT and Alzheimer disease: In addition, insulin suppresses the activity of GSK-3ß, a well-known Tau kinase (Lei et al., 2011), hence the loss of insulin signaling initiates Tau hyperphosphorylation and aggregation in AD (Hong and Lee, 1997; Schubert et al., 2003, 2004).